Influence of neoadjuvant chemoradiotherapy on PD-L1 expression change in rectal cancer patients

Simple item page
dc.contributor.authorRichter Igorcs
dc.contributor.authorDvořák Josefcs
dc.contributor.authorBartoš Jiřícs
dc.contributor.authorJirásek Tomášcs
dc.date.accessioned2020-06-08T09:46:00Z
dc.date.available02-46-2020en
dc.date.available2020-06-08T09:46:00Z
dc.date.issued2019cs
dc.date.updated11-06-2020en
dc.format.extent10cs
dc.identifier.issn2464-7195cs
dc.identifier.urihttps://dspace.tul.cz/handle/15240/156241
dc.language.isoczecs
dc.publisherCurrent Media s.r.o.cs
dc.publisher.cityPrahacs
dc.relation.ispartofOnkologická revueen
dc.relation.ispartofseries0cs
dc.subjectrectal adenocarcinomacs
dc.subjectneoadjuvant chemoradiotherapycs
dc.subjectimmunotherapycs
dc.subjectPD-1/PD-L1cs
dc.titleInfluence of neoadjuvant chemoradiotherapy on PD-L1 expression change in rectal cancer patientsen
dc.titleVliv neoadjuvantní chemoradioterapie na změnu exprese PD-L1 u pacientů s karcinomem rektacs
local.citation.epage52-61cs
local.citation.spage52-61cs
local.identifier.publikace6949
local.relation.issue4cs
Files
Collections